Filing Details

Accession Number:
0001127602-17-006950
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-17 16:33:05
Reporting Period:
2017-02-16
Filing Date:
2017-02-17
Accepted Time:
2017-02-17 16:33:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310142 Sensient Technologies Corp SXT Industrial Organic Chemicals (2860) 390561070
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1059610 Hank Brown 777 East Wisconsin Avenue
Milwaukee WI 53202
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-16 2,000 $26.12 24,861 No 4 M Direct
Common Stock Disposition 2017-02-16 2,000 $79.28 22,861 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2017-02-16 2,000 $0.00 2,000 $26.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-05-01 2017-05-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,700 Indirect By Spouse
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $30.07 2009-05-01 2018-05-01 2,000 2,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-05-01 2,000 2,000 Direct
Footnotes
  1. Exercise of in-the-money stock option that would otherwise expire on 5/1/2017, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
  2. Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan.
  3. This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $79.27 to $79.29. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.